Browse By: Country ι Category ι Latest Reports ι Tag
Home  »  Current Partnering

Current Partnering Market Research Reports

Current Partnering: The source of best practice for dealmakers

Current Partnering is the leading publisher of partnering deal terms and best practice for dealmakers. Report titles cover all aspects of partnering best practice and deal terms, providing users with the information and insight required to optimise their partnering activities. 



Global Hematology Partnering 2010-2015: Deal trends, players and financials
The Global Hematology Partnering 2010-2015 report provides an understanding and access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hematology partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Hematology partnering contract documents Top hematology deals by value The Global Hematology Partnering 2010-2015 report provides an understanding and access to the hematology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter hematology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Hospital Care Partnering 2010-2015: Deal trends, players and financials
The Global Hospital Care Partnering 2010-2015 report provides an understanding and access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hospital care partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Hospital care partnering contract documents Top hospital care deals by value The Global Hospital Care Partnering 2010-2015 report provides an understanding and access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter hospital care partnering deals. The majority of deals are development stage whereby the licensee obta
Published Date: Jun 2015
Published By: Current Partnering

Price: $3495
Global Genetic Disorders Partnering 2010-2015: Deal trends, players and financials
The Global Genetic disorders Partnering 2010-2015 report provides an understanding and access to the genetic disorders partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in genetic disorders partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Genetic disorders partnering contract documents Top genetic disorders deals by value The Global Genetic disorders Partnering 2010-2015 report provides an understanding and access to the genetic disorders partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter genetic disorders partnering deals. The majority of deals are developme
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Respiratory Partnering 2010-2015: Deal trends, players and financials
The Global Respiratory Partnering 2010-2015 report provides an understanding and access to the respiratory partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in respiratory partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Respiratory partnering contract documents Top respiratory deals by value The Global Respiratory Partnering 2010-2015 report provides an understanding and access to the respiratory partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter respiratory partnering deals. The majority of deals are development stage whereby the licensee obtains a right or a
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Central Nervous System Partnering 2010-2015: Deal trends, players and financials
The Global Central Nervous System Partnering 2010-2015 report provides an understanding and access to the central nervous system partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in central nervous system partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Central nervous system partnering contract documents Top central nervous system deals by value The Global Central Nervous System Partnering 2010-2015 report provides an understanding and access to the central nervous system partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter central nervous system partnering deal
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Psychiatry Partnering 2010-2015: Deal trends, players and financials
The Global Psychiatry Partnering 2010-2015 report provides an understanding and access to the psychiatry partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in psychiatry partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Psychiatry partnering contract documents Top psychiatry deals by value The Global Psychiatry Partnering 2010-2015 report provides an understanding and access to the psychiatry partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter psychiatry partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Musculoskeletal Partnering 2010-2015: Deal trends, players and financials
The Global Musculoskeletal Partnering 2010-2015 report provides an understanding and access to the musculoskeletal partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in musculoskeletal partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Musculoskeletal partnering contract documents Top musculoskeletal deals by value The Global Musculoskeletal Partnering 2010-2015 report provides an understanding and access to the musculoskeletal partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter musculoskeletal partnering deals. The majority of deals are development stage whereby t
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Cardiovascular Partnering 2010-2015: Deal trends, players and financials
The Global Cardiovascular Partnering 2010-2015 report provides an understanding and access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in cardiovascular partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cardiovascular partnering contract documents Top cardiovascular deals by value The Global Cardiovascular Partnering 2010-2015 report provides an understanding and access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are development stage whereby the licen
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Metabolic Partnering 2010-2015: Deal trends, players and financials
The Global Metabolic Partnering 2010-2015 report provides an understanding and access to the metabolic partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in metabolic partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Metabolic partnering contract documents Top metabolic deals by value The Global Metabolic Partnering 2010-2015 report provides an understanding and access to the metabolic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter metabolic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right t
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Immunology Partnering 2010-2015: Deal trends, players and financials
The Global Immunology Partnering 2010-2015 report provides an understanding and access to the immunology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in immunology partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Immunology partnering contract documents Top immunology deals by value The Global Immunology Partnering 2010-2015 report provides an understanding and access to the immunology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Ophthalmics Partnering 2010-2015: Deal trends, players and financials
The Global Ophthalmics Partnering 2010-2015 report provides an understanding and access to the ophthalmics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ophthalmics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Ophthalmics partnering contract documents Top ophthalmics deals by value The Global Ophthalmics Partnering 2010-2015 report provides an understanding and access to the ophthalmics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter ophthalmics partnering deals. The majority of deals are development stage whereby the licensee obtains a right or a
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Dermatology Partnering 2010-2015: Deal trends, players and financials
The Global Dermatology Partnering 2010-2015 report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dermatology partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Dermatology partnering contract documents Top dermatology deals by value The Global Dermatology Partnering 2010-2015 report provides an understanding and access to the dermatology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or a
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Sensory Organ Partnering 2010-2015: Deal trends, players and financials
The Global Sensory Organ Partnering 2010-2015 report provides an understanding and access to the sensory organ partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sensory organ partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Sensory organ partnering contract documents Top sensory organ deals by value The Global Sensory organ Partnering 2010-2015 report provides an understanding and access to the sensory organ partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter sensory organ partnering deals. The majority of deals are development stage whereby the licensee obta
Published Date: Jun 2015
Published By: Current Partnering

Price: $995
Global Public Health Partnering 2010-2015: Deal trends, players and financials
The Global Public Health Partnering 2010-2015 report provides an understanding and access to the public health partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in public health partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Public health partnering contract documents Top public health deals by value The Global Public Health Partnering 2010-2015 report provides an understanding and access to the public health partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter public health partnering deals. The majority of deals are development stage whereby the licensee obta
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Pediatrics Partnering 2010-2015: Deal trends, players and financials
The Global Pediatrics Partnering 2010-2015 report provides an understanding and access to the pediatrics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in pediatrics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Pediatrics partnering contract documents Top pediatrics deals by value The Global Pediatrics Partnering 2010-2015 report provides an understanding and access to the pediatrics partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter pediatrics partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Gynecology Partnering 2010-2015: Deal trends, players and financials
The Global Gynecology Partnering 2010-2015 report provides an understanding and access to the gynecology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gynecology partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gynecology partnering contract documents Top gynecology deals by value The Global Gynecology Partnering 2010-2015 report provides an understanding and access to the gynecology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter gynecology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Gastrointestinal Partnering 2010-2015: Deal trends, players and financials
The Global Gastrointestinal Partnering 2010-2015 report provides an understanding and access to the gastrointestinal partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gastrointestinal partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gastrointestinal partnering contract documents Top gastrointestinal deals by value The Global Gastrointestinal Partnering 2010-2015 report provides an understanding and access to the gastrointestinal partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter gastrointestinal partnering deals. The majority of deals are development stage w
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Dental Partnering 2010-2015: Deal trends, players and financials
The Global Dental Partnering 2010-2015 report provides an understanding and access to the dental partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dental partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Dental partnering contract documents Top dental deals by value The Global Dental Partnering 2010-2015 report provides an understanding and access to the dental partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter dental partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Oncology Partnering 2010-2015: Deal trends, players and financials
The Global Oncology Partnering 2010-2015 report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in oncology partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Oncology partnering contract documents Top oncology deals by value The Global Oncology Partnering 2010-2015 report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter oncology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to licens
Published Date: Jun 2015
Published By: Current Partnering

Price: $3495
Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the asset purchase agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter asset purchase deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
Published Date: Jun 2015
Published By: Current Partnering

Price: $2995
Global Companion Diagnostics Partnering 2010-2015 : Deal trends, players, financials and forecasts
The Global Companion Diagnostics Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the companion diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Personalized Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts
The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract docume
Published Date: Jun 2015
Published By: Current Partnering

Price: $3495
Global COPD Partnering 2010-2015
The COPD Partnering 2010-2015 report provides understanding and access to the COPD partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in COPD partnering deals Top COPD deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The COPD Partnering 2010-2015 provides understanding and access to the COPD partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of COPD partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors COPD technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization o
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Obesity Partnering 2010-2015
Obesity Partnering 2010-2015 report provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in obesity partnering deals Top obesity deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Obesity Partnering 2010-2015 provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of obesity partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors obesity technology. These deals tend to be multicomponent, starting with collaborative R&D, and com
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Dementia Partnering 2010-2015
The Dementia Partnering 2010-2015 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dementia partnering deals Top dementia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dementia Partnering 2010-2015 provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dementia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dementia technology. These deals tend to be multicomponent, starting with collaborative
Published Date: Jun 2015
Published By: Current Partnering

Price: $1995
Global Depression Partnering 2010-2015
The Depression Partnering 2010-2015 report provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in depression partnering deals Top depression deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Depression Partnering 2010-2015 provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of depression partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors depression technology. These deals tend to be multicomponent, starting wit
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Sleep Disorders Partnering 2010-2015
The Sleep Disorders Partnering 2010-2015 report provides understanding and access to the sleep disorders partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sleep disorders partnering deals Top sleep disorders deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sleep Disorders Partnering 2010-2015 provides understanding and access to the sleep disorders partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of sleep disorders partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sleep disorders technology. These deals
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Retinopathy Partnering 2010-2015
The Retinopathy Partnering 2010-2015 report provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in retinopathy partnering deals Top retinopathy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of retinopathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors retinopathy technology. These deals tend to be multicomponent, star
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Glaucoma Partnering 2010-2015
The Glaucoma Partnering 2010-2015 report provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in glaucoma partnering deals Top glaucoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Glaucoma Partnering 2010-2015 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of glaucoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors glaucoma technology. These deals tend to be multicomponent, starting with collaborative
Published Date: Jun 2015
Published By: Current Partnering

Price: $1495
Global Infectious Diseases Partnering 2010-2015: Deal trends, players and financials
The Global Infectious Diseases Partnering 2010-2015 report provides an understanding and access to the infectious diseases partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in infectious diseases partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Infectious diseases partnering contract documents Top infectious diseases deals by value The Global Infectious Diseases Partnering 2010-2015 report provides an understanding and access to the infectious diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter infectious diseases partnering deals. The majority of deals
Published Date: Jun 2015
Published By: Current Partnering

Price: $3495
Inflammatory Partnering 2010-2015
The Inflammatory Partnering 2010-2015 report provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in inflammatory partnering deals Top inflammatory deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Inflammatory Partnering 2010-2015 provides understanding and access to the inflammatory partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of inflammatory partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors inflammatory technology. These deals tend to be multicompone
Published Date: May 2015
Published By: Current Partnering

Price: $995
Age-related Macular Degeneration Partnering 2010-2015
Age-related Macular Degeneration Partnering 2010-2015 report provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in age-related macular degeneration partnering deals Top age-related macular degeneration deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Age-related Macular Degeneration Partnering 2009-2014 provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of age-related macular degeneration partnering deals. The majority of deals are discovery or development stage whereby t
Published Date: May 2015
Published By: Current Partnering

Price: $795
Global Sexual Health Partnering 2010-2015: Deal trends, players and financials
The Global Sexual Health Partnering 2010-2015 report provides an understanding and access to the sexual health partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sexual health partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Sexual health partnering contract documents Top sexual health deals by value The Global Sexual Health Partnering 2010-2015 report provides an understanding and access to the sexual health partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter sexual health partnering deals. The majority of deals are development stage whereby the licensee obta
Published Date: May 2015
Published By: Current Partnering

Price: $995
Herpes simplex Partnering 2010-2015
The Herpes Simplex Partnering 2010-2015 report provides understanding and access to the herpes simplex partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in herpes simplex partnering deals Top herpes simplex deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Herpes Simplex Partnering 2010-2015 provides understanding and access to the herpes simplex partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of herpes simplex partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors herpes simplex technology. These deals
Published Date: May 2015
Published By: Current Partnering

Price: $795
Hepatitis Partnering 2010-2015
The Hepatitis Partnering 2010-2015 report provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hepatitis partnering deals Top hepatitis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hepatitis Partnering 2010-2015 provides understanding and access to the hepatitis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hepatitis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hepatitis technology. These deals tend to be multicomponent, starting with co
Published Date: May 2015
Published By: Current Partnering

Price: $995
MRSA Partnering 2010-2015
The MRSA Partnering 2010-2015 report provides understanding and access to the MRSA partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in MRSA partnering deals Top MRSA deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The MRSA Partnering 2010-2015 provides understanding and access to the MRSA partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of MRSA partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors MRSA technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercializa
Published Date: May 2015
Published By: Current Partnering

Price: $795
Viral Partnering Terms and Agreements
The Viral Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the viral partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in viral partnering deals Average deal terms for headline, upfront and royalty by stage of development Viral partnering agreement structure Viral partnering contract documents Top viral deals by value Most active viral dealmakers The Viral Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the viral partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter viral partnering deals. The ma
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Dry Eye Partnering 2010-2015
The Dry eye Partnering 2010-2015 report provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dry eye partnering deals Top dry eye deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dry eye Partnering 2010-2015 provides understanding and access to the dry eye partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dry eye partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dry eye technology. These deals tend to be multicomponent, starting with collaborative R&
Published Date: May 2015
Published By: Current Partnering

Price: $795
Retinopathy Partnering 2010-2015
The Retinopathy Partnering 2010-2015 report provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in retinopathy partnering deals Top retinopathy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of retinopathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors retinopathy technology. These deals tend to be multicomponent
Published Date: May 2015
Published By: Current Partnering

Price: $795
Allergy Partnering 2010-2015
The Allergy Partnering 2010-2015 report provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in allergy partnering deals Top allergy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Allergy Partnering 2010-2015 provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of allergy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors allergy technology. These deals tend to be multicomponent, starting with collaborative R&
Published Date: May 2015
Published By: Current Partnering

Price: $795
AIDS Partnering 2010-2015
The AIDS Partnering 2010-2015 report provides understanding and access to the AIDS partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in AIDS partnering deals Top AIDS deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The AIDS Partnering 2010-2015 provides understanding and access to the AIDS partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of AIDS partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors AIDS technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercializati
Published Date: May 2015
Published By: Current Partnering

Price: $795
Global Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts
The Global Biomarker Partnering 2010-2015: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Global Biomarker Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter biomarker partnering deals. The
Published Date: May 2015
Published By: Current Partnering

Price: $2995
Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2015
The Global Option and Evaluation Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent whereby the licensor offers a right to option and evaluation the resultant product of the research collaboration. There are also numerous pure option and evaluation deals whereby the products originator takes on a partner in order to maximize a products presence in the marketplace. Understanding the flexibility of a prospective partner’s negotiated deals terms provide
Published Date: May 2015
Published By: Current Partnering

Price: $2995
Sexual Dysfunction Partnering 2010-2015
The Sexual Dysfunction Partnering 2010-2015 report provides understanding and access to the sexual dysfunction partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sexual dysfunction partnering deals Top sexual dysfunction deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sexual Dysfunction Partnering 2010-2015 provides understanding and access to the sexual dysfunction partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of sexual dysfunction partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sexual dysfu
Published Date: May 2015
Published By: Current Partnering

Price: $795
Asthma Partnering 2010-2015
The Asthma Partnering 2009-2014 report provides understanding and access to the asthma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in asthma partnering deals Top asthma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Asthma Partnering 2009-2014 provides understanding and access to the asthma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of asthma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors asthma technology. These deals tend to be multicomponent, starting with collaborative R&D, a
Published Date: May 2015
Published By: Current Partnering

Price: $795
Drug Addiction Partnering 2010-2015
Drug Addiction Partnering 2009-2014 report provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare companies. •Trends in drug addiction partnering deals •Top drugs deal addiction by value •Deals listed by company A-Z, industry sector, stage of development, technology type Drug Addiction Partnering 2009-2014 provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of drug addiction partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug addiction technology. These dea
Published Date: May 2015
Published By: Current Partnering

Price: $795
Alzheimers Disease Partnering 2010-2015
The Alzheimer’s Disease Partnering 2010-2015 report provides understanding and access to the alzheimer’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in alzheimer’s disease partnering deals Top alzheimer’s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Alzheimer ’s Disease Partnering 2010-2015 provides understanding and access to the alzheimer’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of alzheimer’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Sleep Disorders Partnering 2010-2015
The Sleep Disorders Partnering 2010-2015 report provides understanding and access to the sleep disorders partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sleep disorders partnering deals Top sleep disorders deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sleep Disorders Partnering 2010-2015 provides understanding and access to the sleep disorders partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of sleep disorders partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sleep disorders technology. These d
Published Date: May 2015
Published By: Current Partnering

Price: $795
Accident & Emergency Partnering 2010-2015
Accident & Emergency Partnering 2009-2014 report provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in accident & emergency partnering deals Top accident & emergency deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Accident & Emergency Partnering 2009-2014 provides understanding and access to the accident & emergency partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of accident & emergency partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to li
Published Date: May 2015
Published By: Current Partnering

Price: $995
COPD Partnering 2010-2015
The COPD Partnering 2009-2014 report provides understanding and access to the COPD partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in COPD partnering deals Top COPD deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The COPD Partnering 2009-2014 provides understanding and access to the COPD partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of COPD partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors COPD technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercia
Published Date: May 2015
Published By: Current Partnering

Price: $795
Anemia Partnering 2010-2015
The Anemia Partnering 2010-2015 report provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in anemia partnering deals Top anemia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Anemia Partnering 2010-2015 provides understanding and access to the anemia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of anemia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors anemia technology. These deals tend to be multicomponent, starting with collaborative R&D, a
Published Date: May 2015
Published By: Current Partnering

Price: $795
Human Papilloma Virus Partnering 2010-2015
The Human Papilloma virus Partnering 2010-2015 report provides understanding and access to the human papilloma virus partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in human papilloma virus partnering deals Top human papilloma virus deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Human Papilloma virus Partnering 2010-2015 provides understanding and access to the human papilloma virus partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of human papilloma virus partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the l
Published Date: May 2015
Published By: Current Partnering

Price: $795
Obesity Partnering 2010-2015
Obesity Partnering 2009-2014 report provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in obesity partnering deals Top obesity deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Obesity Partnering 2009-2014 provides understanding and access to the obesity partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of obesity partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors obesity technology. These deals tend to be multicomponent, starting with collaborative R&D, a
Published Date: May 2015
Published By: Current Partnering

Price: $995
Ebola Partnering 2010-2015
The Ebola Partnering 2010-2015 report provides understanding and access to the ebola partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in ebola partnering deals Top ebola deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Ebola Partnering 2010-2015 provides understanding and access to the ebola partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of ebola partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ebola technology. These deals tend to be multicomponent, starting with collaborative R&D, and commerc
Published Date: May 2015
Published By: Current Partnering

Price: $795
Clostridium difficile Partnering 2010-2015
The Clostridium difficile Partnering 2010-2015 report provides understanding and access to the Clostridium difficile partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Clostridium difficile partnering deals Top Clostridium difficile deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Clostridium difficile Partnering 2010-2015 provides understanding and access to the Clostridium difficile partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of Clostridium difficile partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the l
Published Date: May 2015
Published By: Current Partnering

Price: $795
Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015
The Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides detailed understanding and analysis of how and why companies enter royalty financing deals. Comprehensive directory of royalty financing deals since 2007 Royalty financing contract documents Royalty financing agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers The Global Royalty Financing Deals in Pharma, Biotech and Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the royalty financing agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter royalty financing
Published Date: May 2015
Published By: Current Partnering

Price: $1995
Dementia Partnering 2010-2015
The Dementia Partnering 2010-2015 report provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dementia partnering deals Top dementia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dementia Partnering 2010-2015 provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dementia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dementia technology. These deals tend to be multicomponent, starting with collabor
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Depression Partnering 2010-2015
The Depression Partnering 2010-2015 report provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in depression partnering deals Top depression deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Depression Partnering 2010-2015 provides understanding and access to the depression partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of depression partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors depression technology. These deals tend to be multicomponent, starti
Published Date: May 2015
Published By: Current Partnering

Price: $795
Schizophrenia Partnering 2010-2015
The Schizophrenia Partnering 2010-2015 report provides understanding and access to the schizophrenia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in schizophrenia partnering deals Top schizophrenia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Schizophrenia Partnering 2010-2015 provides understanding and access to the schizophrenia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of schizophrenia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors schizophrenia technology. These deals tend to be mu
Published Date: May 2015
Published By: Current Partnering

Price: $795
Global Orphan Diseases Partnering 2010-2015: Deal trends, players and financials
The Global Orphan Diseases Partnering 2010-2015 report provides an understanding and access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in orphan diseases partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Orphan diseases partnering contract documents Top orphan diseases deals by value The Global Orphan Diseases Partnering 2010-2015 report provides an understanding and access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter orphan diseases partnering deals. The majority of deals are development stage where
Published Date: May 2015
Published By: Current Partnering

Price: $1995
Transplantation Partnering 2010-2015
Transplantation Partnering 2009-2014 report provides understanding and access to the transplantation partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in transplantation partnering deals Top transplantation deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Transplantation Partnering 2009-2014 provides understanding and access to the transplantation partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of transplantation partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors transplantation technology. These deals tend to
Published Date: May 2015
Published By: Current Partnering

Price: $995
Systemic Lupus Erythematosus Partnering 2010-2015
The Systemic Lupus erythematosus Partnering 2010-2015 report provides understanding and access to the systemic lupus erythematosus partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in systemic lupus erythematosus partnering deals Top systemic lupus erythematosus deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Systemic Lupus Erythematosus Partnering 2010-2015 provides understanding and access to the systemic lupus erythematosus partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of systemic lupus erythematosus partnering deals. The majority of deals are discovery or development stage whereby the licensee ob
Published Date: May 2015
Published By: Current Partnering

Price: $795
Hearing Disorders Partnering 2010-2015
The Hearing Disorders Partnering 2010-2015 report provides understanding and access to the hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hearing disorders partnering deals Top hearing disorders deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hearing Disorders Partnering 2010-2015 provides understanding and access to the hearing disorders partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hearing disorders partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hearing disorders t
Published Date: May 2015
Published By: Current Partnering

Price: $795
Surgery Partnering 2010-2015
Surgery Partnering 2009-2014 report provides understanding and access to the surgery partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in surgery partnering deals Top surgery deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Surgery Partnering 2009-2014 provides understanding and access to the surgery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of surgery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors surgery technology. These deals tend to be multicomponent, starting with collaborative R&D, and com
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Cystic Fibrosis Partnering 2010-2015
The Cystic Fibrosis Partnering 2010-2015 report provides understanding and access to the Cystic fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Cystic fibrosis partnering deals Top Cystic fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Cystic fibrosis Partnering 2010-2015 provides understanding and access to the Cystic fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of Cystic fibrosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors Cystic fibrosis technology. These
Published Date: May 2015
Published By: Current Partnering

Price: $795
Idiopathic Pulmonary Fibrosis Partnering 2010-2015
The Idiopathic Pulmonary Fibrosis Partnering 2010-2015 report provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in idiopathic pulmonary fibrosis partnering deals Top idiopathic pulmonary fibrosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Idiopathic Pulmonary Fibrosis Partnering 2010-2015 provides understanding and access to the idiopathic pulmonary fibrosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of idiopathic pulmonary fibrosis partnering deals. The majority of deals are discovery or development stage whereby the li
Published Date: May 2015
Published By: Current Partnering

Price: $795
Hemophilia Partnering 2010-2015
The Hemophilia Partnering 2010-2015 report provides understanding and access to the hemophilia partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in hemophilia partnering deals Top hemophilia deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Hemophilia Partnering 2010-2015 provides understanding and access to the hemophilia partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of hemophilia partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors hemophilia technology. These deals tend to be multicomponent, starting wit
Published Date: May 2015
Published By: Current Partnering

Price: $795
Infertility Partnering 2010-2015
The Infertility Partnering 2010-2015 report provides understanding and access to the infertility partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in infertility partnering deals Top infertility deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Infertility Partnering 2010-2015 provides understanding and access to the infertility partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of infertility partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors infertility technology. These deals tend to be multicomponent, star
Published Date: May 2015
Published By: Current Partnering

Price: $795
Tuberculosis Partnering 2010-2015
The Tuberculosis Partnering 2010-2015 report provides understanding and access to the tuberculosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in tuberculosis partnering deals Top tuberculosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Tuberculosis Partnering 2010-2015 provides understanding and access to the tuberculosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of tuberculosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors tuberculosis technology. These deals tend to be multicompone
Published Date: May 2015
Published By: Current Partnering

Price: $995
Malaria Partnering 2010-2015
The Malaria Partnering 2010-2015 report provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in malaria partnering deals Top malaria deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Malaria Partnering 2010-2015 provides understanding and access to the malaria partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of malaria partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors malaria technology. These deals tend to be multicomponent, starting with collaborative R&D,
Published Date: May 2015
Published By: Current Partnering

Price: $795
Fungal Partnering 2010-2015
The Fungal Diseases Partnering 2010-2015 provides understanding and access to the fungal diseases partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in fungal diseases partnering deals Top fungal diseases deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Fungal Diseases Partnering 2010-2015 provides understanding and access to the fungal diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of fungal diseases partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors fungal diseases technology. These deals tend t
Published Date: May 2015
Published By: Current Partnering

Price: $795
Influenza Partnering 2010-2015
The Influenza Partnering 2010-2015 report provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in influenza partnering deals Top influenza deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Influenza Partnering 2010-2015 provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of influenza partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors influenza technology. These deals tend to be multicomponent, starting with collab
Published Date: May 2015
Published By: Current Partnering

Price: $995
Dengue Fever Partnering 2010-2015
The Dengue Fever Partnering 2010-2015 report provides understanding and access to the dengue fever partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in dengue fever partnering deals Top dengue fever deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Dengue fever Partnering 2010-2015 provides understanding and access to the dengue fever partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of dengue fever partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dengue fever technology. These deals tend to be multicom
Published Date: May 2015
Published By: Current Partnering

Price: $795
Sepsis Partnering 2010-2015
The Sepsis Partnering 2010-2015 report provides understanding and access to the sepsis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in sepsis partnering deals Top sepsis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sepsis Partnering 2010-2015 provides understanding and access to the sepsis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of sepsis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors sepsis technology. These deals tend to be multicomponent, starting with collaborative R&D, and com
Published Date: May 2015
Published By: Current Partnering

Price: $795
Tropical Disease Partnering 2010-2015
The Tropical Diseases Partnering 2010-2015 report provides understanding and access to the tropical diseases partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in tropical diseases partnering deals Top tropical diseases deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Tropical Diseases Partnering 2010-2015 provides understanding and access to the tropical diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of tropical diseases partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors tropical diseases tec
Published Date: May 2015
Published By: Current Partnering

Price: $795
Parasitic Disease Partnering 2010-2015
The Parasitic Partnering 2010-2015 report provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in parasitic partnering deals Top parasitic deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Parasitic Partnering 2010-2015 provides understanding and access to the parasitic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of parasitic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors parasitic technology. These deals tend to be multicomponent, starting wit
Published Date: May 2015
Published By: Current Partnering

Price: $795
Anthrax Partnering 2010-2015
The Anthrax Partnering 2010-2015 report provides understanding and access to the anthrax partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in anthrax partnering deals Top anthrax deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Anthrax Partnering 2010-2015 provides understanding and access to the anthrax partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of anthrax partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors anthrax technology. These deals tend to be multicomponent, starting with collaborative R&D,
Published Date: May 2015
Published By: Current Partnering

Price: $795
HIV Partnering 2010-2015
The HIV Partnering 2010-2015 report provides understanding and access to the HIV partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in HIV partnering deals Top HIV deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The HIV Partnering 2010-2015 provides understanding and access to the HIV partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of HIV partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors HIV technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Bacterial Partnering Terms and Agreements
The Bacterial Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the bacterial partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in bacterial partnering deals Average deal terms for headline, upfront and royalty by stage of development Bacterial partnering agreement structure Bacterial partnering contract documents Top bacterial deals by value Most active bacterial dealmakers The Bacterial Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the bacterial partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies ente
Published Date: May 2015
Published By: Current Partnering

Price: $1795
Glaucoma Partnering 2010-2015
The Glaucoma Partnering 2010-2015 report provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in glaucoma partnering deals Top glaucoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Glaucoma Partnering 2010-2015 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of glaucoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors glaucoma technology. These deals tend to be multicomponent, starting with collaborative
Published Date: May 2015
Published By: Current Partnering

Price: $795
Top 50 Big Biotech Partnering and M&A Deal Trends
Global SaaS-based Project and Portfolio Management (PPM) Market 2015-2019 Global Shunt Reactor Market 2015-2019  The Top 50 Big Biotech Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big biotech companies. Top 50 Big Biotech Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big biotech companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2010 – number of deals per year Full listing of partnering deals Activity by
Published Date: Apr 2015
Published By: Current Partnering

Price: $2495
Finding Biopharma Licensing and Collaboration Partners
Current Partnering’s Finding Biopharma Licensing and Collaboration Partners provides a comprehensive overview of all the steps required to identify and secure potential partnering opportunities either for an in-licensing or out-licensing activity. The report takes the reader through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to deal negotiation. In addition, the report provides a detailed overview of the activities a business development executive and a company should be undertaking to build and maintain an extensive contact network, and to become partner of choice, respe
Published Date: Apr 2015
Published By: Current Partnering

Price: $1495
Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015
The Global Co-development Deals in Pharma, Biotech & Diagnostics 2010-2015 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading life science companies. The report provides a detailed understand and analysis of how and why companies enter co-development deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred – contract documents provide this insight whe
Published Date: Apr 2015
Published By: Current Partnering

Price: $2995
Top 50 Big Pharma Partnering and M&A Deal Trends
The Top 50 Big Pharma Partnering and M&A Deal Trends report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty big pharma companies. Top 50 Big Pharma Partnering and M&A Deal Trends provides the user with the following key benefits: Detailed partnering activity profiles for each of the top 50 big pharma companies Over 300 charts showing a company’s dealmaking activity since 2009, allowing quick identification potential partners Partnering therapy focus revealed Partnering activity since 2010 – number of deals per year Full listing of partnering deals Activity by deal type Activity by industry sector Activity by phase of development Activity by technology type Activity by therapeu
Published Date: Apr 2015
Published By: Current Partnering

Price: $3495
Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and forecasts
The Global Regenerative Medicine Partnering 2010-2015: Deal trends, players, financials and  forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in regenerative medicine  Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for regenerative medicine and stem cells Track future trends and emerging companies in regenerative medicine- *new feature* The report takes readers through the regenerative medicine deal trends, key players and top deal val
Published Date: Apr 2015
Published By: Current Partnering

Price: $2995
Genitourinary Deals and Alliances of 2014
The Genitourinary Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Genetic Disorders Deals and Alliances of 2014
The Genetic Disorders Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfron
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Multiple Sclerosis Partnering 2010-2015
The Multiple Sclerosis Partnering 2010-2015 report provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in multiple sclerosis partnering deals Top multiple sclerosis deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Multiple Sclerosis Partnering 2010-2015 provides understanding and access to the multiple sclerosis partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of multiple sclerosis partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors multiple
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Gastrointestinal Deals and Alliances of 2014
The Gastrointestinal Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Inflammatory Bowel Disease Partnering 2010-2015
The Inflammatory Bowel Disease Partnering 2010-2015 report provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in inflammatory bowel disease partnering deals Top inflammatory bowel disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Inflammatory Bowel Disease Partnering 2010-2015 provides understanding and access to the inflammatory bowel disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of inflammatory bowel disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a righ
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Central Nervous System Deals and Alliances of 2014
The Central Nervous System Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, u
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Cardiovascular Deals and Alliances of 2014
The Cardiovascular Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront,
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Crohns Disease Partnering 2010-2015
The Crohn’s disease Partnering 2010-2015 report provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Crohn’s disease partnering deals Top Crohn’s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Crohn’s Disease Partnering 2010-2015 provides understanding and access to the Crohn’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of Crohn’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license t
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Hospital Care Deals and Alliances of 2014
The Hospital Care Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication. Chapter 2 provides a comprehensive listing of deals by average headline, upfront, m
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495
Motor Neurone Disease Partnering 2010-2015
The Motor Neurone Partnering 2010-2015 report provides understanding and access to the motor neurone partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in motor neurone partnering deals Top motor neurone deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Motor Neurone Partnering 2010-2015 provides understanding and access to the motor neurone partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of motor neurone partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors motor neurone technology. These deals tend
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Autoimmune Partnering Terms and Agreements
The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in autoimmune partnering deals Average deal terms for headline, upfront and royalty by stage of development Autoimmune partnering agreement structure Autoimmune partnering contract documents Top autoimmune deals by value Most active autoimmune dealmakers The Autoimmune Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and w
Published Date: Mar 2015
Published By: Current Partnering

Price: $2995
Non-Hodgkin Lymphoma Partnering 2010-2015
The Non-Hodgkin Lymphoma Partnering 2010-2015 report provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in non-hodgkin lymphoma partnering deals Top non-hodgkin lymphoma deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Non-Hodgkin Lymphoma Partnering 2010-2015 provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of non-hodgkin lymphoma partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors non-
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Parkinsons Disease Partnering 2010-2015
The Parkinson’s Disease Partnering 2010-2015 report provides understanding and access to the parkinson’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in parkinson’s disease partnering deals Top parkinson’s disease deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Parkinson’s disease Partnering 2010-2015 provides understanding and access to the parkinson’s disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of parkinson’s disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or
Published Date: Mar 2015
Published By: Current Partnering

Price: $995
Neuropathy Partnering 2010-2015
The Neuropathy Partnering 2010-2015 report provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in neuropathy partnering deals Top neuropathy deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Neuropathy Partnering 2010-2015 provides understanding and access to the neuropathy partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of neuropathy partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors neuropathy technology. These deals tend to be multicomponent, star
Published Date: Mar 2015
Published By: Current Partnering

Price: $795
Big pharma Deals and Alliances of 2014
The Big Pharma Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities. Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, stage of development, technology type and therapeutic indication. Chapter 2 provides a review of the leading deals during 2014. De
Published Date: Mar 2015
Published By: Current Partnering

Price: $1495